Martin Bak, PostDoc06. November 2018

  • What motivated you to become a scientist?

    Since starting school, I have been greatly interested in chemistry, physics and biology. Initially, it was probably only due to the visual wonders of science, but it later became an urge to gain a greater understanding of various processes in nature. My main fascination with chemistry started in high school and resulted in me getting a chemical engineer education. Having a highly innovative environment with applied science that could potentially help people motivated me greatly to continue my science career. 

  • How did you end up doing what you do today?

    I finished my Master’s degree at the Technical University of Denmark as a chemical engineer within organic synthesis and medicinal development back in 2013. I finished off with a thesis about surface modifications of liposomal drug delivery systems. The research continued to be interesting and I found it particularly fascinating to see that some of my projects could potentially be applied to patients in the future. Spinout companies created within the group exemplified that. My projects developed into many different branches of the drug delivery field. After a short period as a Research Assistant, this lead to my PhD position within the RIBBD initiative. The five years I have now spent in this field have been a fascinating journey with many frustrations as well as many great projects that could potentially help many people in real life applications. 

  • What are you working on at the moment?

    I am currently involved in several projects on drug delivery to the brain and immunotherapy. These includes projects focusing on how affinity and avidity of targeting proteins affect drug delivery of nanoparticles to the brain. We recently published a paper about this study in Journal of Theranostics. Additionally, I am synthesizing various bioreducible compounds that can be used to facilitate better drug delivery to the brain by liposomes. This includes a redox-sensitive liposomal drug delivery system and a self-reporting nanoparticle system. 

  • What do you think the most exciting thing about being a scientist is?

    Well, it is fascinating to work in a highly innovative environment where we come together in a multidisciplinary team to create new and exciting projects that can materialize into treatments for patients, patents, and manuscripts. The diversity and constant flow of new collaborative projects is greatly inspiring.

  • What do you do when you are not working?

    In my spare time, I run, climb, brew beer, and cook for friends and family. I have started exploring the wonders of molecular gastronomy, as I like to have a chemical understanding of the different processes in cooking.